Advertisement

Inflammation and Repair

  • H. L. Wong
  • S. M. Wahl
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 95 / 2)

Abstract

Injuries to tissue, whether due to mechanical, chemical, immunological, or thermal insults, initiate an orderly but complex series of cellular and biochemical interactions that lead to the formation of new tissue and the eventual repair of the wound. The cellular components of this pathway include hematopoietic cells such as platelets, polymorphonuclear leukocytes, lymphocytes, and monocytes, and mesenchymal cells such as fibroblasts and endothelial cells. These cells migrate to the site of tissue damage in a sequence determined by soluble factors that are released at the site of injury through a wide variety of mechanisms. Among these are tissue breakdown, blood coagulation, and cellular release. Each cell type has a specific function to perform such as degradation and resorption of damaged tissue, protection against infection, or deposition of new extracellular matrix.

Keywords

Arachidonic Acid Metabolite Hepatic Granuloma Streptococcal Cell Wall Fibroblast Population Cell BioI 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aarden LA, Lansdorp PM, DeGroot ER (1985) A growth factor for B cell hybridomas produced by human monocytes. Lymphokines 10: 175–186Google Scholar
  2. Adelmann-Grill BC, Heinz R, Wach F, Krieg T (1987) Inhibition of fibroblast chemotaxis by recombinant human interferon-y and interferon-a. J Cell Physiol 130: 270–275PubMedCrossRefGoogle Scholar
  3. Agelli M, Sobel ME, Wahl SM (1987) Cytokine modulation of fibroblast collagen production. Fed Proc 46: 924Google Scholar
  4. Allen JB, Malone DG, Wahl SM, Calandra GB, Wilder RL (1985) The role of the thymus in streptococcal cell wall-induced arthritis and hepatic granuloma formation: comparative studies of pathology and cell wall distribution in athymic and euthymic rats. J Clin Invest 76: 1042–1056PubMedCrossRefGoogle Scholar
  5. Allen TD, Schor SL (1983) The contraction of collagen matrices by dermal fibroblasts. J Ultrastruct Res 83: 205–219PubMedCrossRefGoogle Scholar
  6. Andersen DC, Schmalsteig FC, Kohl MA, Tosi MF, Dana N, Buffone GJ, Hughes BJ, Brinkley BR, Dickey WD, Abramson JS, Springer T, Boxer LA, Hollers JM, Smith CW (1984) Abnormalities of polymorphonuclear leukocyte function associated with heritable deficiency of a high molecular weight surface glycoprotein (gp 138): common relationship to diminished cell adherence. J Clin Invest 74: 536–551CrossRefGoogle Scholar
  7. Arnaout MA, Wang EA, Clark SC, Sieff CA (1986) Human recombinant granulocyte- macrophage colony-stimulating factor increases cell-cell adhesion and surface expression of adhesion-promoting surface glycoproteins on mature granulocytes. J Clin Invest 78: 597–601PubMedCrossRefGoogle Scholar
  8. Assoian RK, Sporn MB (1986) Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells. J Cell Biol 102: 1217–1223PubMedCrossRefGoogle Scholar
  9. Assoian RK, Frolik CK, Roberts AB, Miller DM, Sporn MB (1984) Transforming growth factor-beta controls receptor levels for epidermal growth factor in NRK fibroblasts. Cell 36: 35–1PubMedCrossRefGoogle Scholar
  10. Assoian RK, Fleurdelys BE, Stevenson HC, Miller PJ, Madtes DK, Raines EW, Ross R, Sporn MB (1987) Expression and secretion of type ß transforming growth factor by activated human macrophages. Proc Natl Acad Sci USA 84: 6020–6024PubMedCrossRefGoogle Scholar
  11. Bagby GC Jr, Dinarello CA, Wallace P, Wagner C, Kefeneider S, McCall E (1986) Interleukin 1 stimulates granulocyte-macrophage colony-stimulating activity release by vascular endothelial cells. J Clin Invest 78: 1316–1323PubMedCrossRefGoogle Scholar
  12. Baird A, Mormede P, Bohlen P (1985) Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggests its identity with macrophage-derived growth factor. Biochem Biophys Res Commun 126: 358–364PubMedCrossRefGoogle Scholar
  13. Banda MJ, Knighton DR, Hunt TK, Werb Z (1982) Isolation of a nonmitogenic angiogenesis factor from wound fluid. Proc Natl Acad Sci USA 79: 7773–7777PubMedCrossRefGoogle Scholar
  14. Bassols A, Massague J (1988) Transforming growth factor regulates the expression and structure of extracellular matrix chondroitin/dermatan sulfate proteoglycans. J Biol Chem 263: 3039–3045PubMedGoogle Scholar
  15. Bauer EA, Cooper TW, Huang JS, Altman J, Deuel TF (1985) Stimulation of in vitro human skin collagenase expression by platelet-derived growth factor. Proc Natl Acad Sci USA 82: 4132–136PubMedCrossRefGoogle Scholar
  16. Baumann H, Muller-Eberhard U (1987) Synthesis of hemopexin and cysteine protease inhibitor is coordinately regulated by HSF-II and interferon-/ß2 in rat hepatoma cells. Biochem Biophys Res Commun 146: 1218–1228PubMedCrossRefGoogle Scholar
  17. Berton G, Zeni L, Cassatella MA, Rossi F (1986) Gamma interferon is able to enhance the oxidative metabolism of human neutrophils. Biochem Biophys Res Commun 138: 1276–1282PubMedCrossRefGoogle Scholar
  18. Beutler BA, Cerami A (1985) Recombinant interleukin 1 suppresses lipoprotein lipase activity in 3T3-L1 cells. J Immunol 135: 3969–3971PubMedGoogle Scholar
  19. Beutler BA, Cerami A (1986) Cachectin and tumor necrosis factor as two sides of the same biological coin. Nature 320: 584–588PubMedCrossRefGoogle Scholar
  20. Bevilacqua MP, Pober JS, Wheeler ME, Cotran RS, Gimbrone MA (1985) Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes and related leukocyte cell lines. J Clin Invest 76: 2003–2011PubMedCrossRefGoogle Scholar
  21. Bitterman PB, Rennard SI, Hunninghake GW, Crystal RG (1982) Human alveolar macrophage growth factor for fibroblasts: regulation and partial characterization. J Clin Invest 70: 806–822PubMedCrossRefGoogle Scholar
  22. Bowen TJ, Ochs HD, Altman LC, Price TH, van Epps DE, Brautigan DL, Rosen RE, Perkins WD, Babior BM, Klebanoff SJ, Wedgewood RJ (1982) Severe recurrent bacterial infections associated with defective adherence and chemotaxis in two patients with neutrophils deficient in a cell-associated glycoprotein. J Pediatr 101: 932PubMedCrossRefGoogle Scholar
  23. Boyle MDP, Lawman MJP, Gee AP, Young MC (1985) Nerve growth factor: a chemotactic factor for polymorphonuclear leukocytes in vivo. J Immunol 134: 564PubMedGoogle Scholar
  24. Brinckerhoff CE, Guyre PM (1985) Increased proliferation of human synovial fibroblasts treated with immune interferon. J Immunol 134: 3142–3146PubMedGoogle Scholar
  25. Broudy VC, Kaushansky K, Segal GM, Harlan JM, Adamson JW (1987) Tumor necrosis factor stimulates human endothelial cells to produce granulo-cyte/macrophage colony-stimulating factor. Proc Natl Acad Sci USA 83: 7467–7471CrossRefGoogle Scholar
  26. Buchanan MR, Crowley CA, Rosin RE, Gimbrone MA Jr, Babior BM (1982) Studies on the interaction between gpl80-deficient neutrophils and vascular endothelium. Blood 60: 160–165PubMedGoogle Scholar
  27. Bullock WE, Wright SD (1987) The role of adherence promoting receptors CR3, LFA- 1 and pi 50,95 in binding of Histoplasma capsulatum by human macrophages. J Exp Med 165: 195–210PubMedCrossRefGoogle Scholar
  28. Buonassisi V (1973) Sulfated mucopolysaccharide synthesis and secretion in endothelial cell cultures. Exp Cell Res 76: 363–368PubMedCrossRefGoogle Scholar
  29. Burd PR, Freeman GJ, Wilson SD, Berman M, DeKruyff R, Billings PR, Dorf ME (1987) Cloning and characterization of a novel T cell activation gene. J Immunol 139: 3126PubMedGoogle Scholar
  30. Carpenter G, Cohen S (1979) Epidermal growth factor. Annu Rev Biochem 48: 193–216PubMedCrossRefGoogle Scholar
  31. Cavender D, Haskard D, Foster N, Ziff M (1987) Superinduction of T lymphocyte- endothelial cell (EC) binding by treatment of EC with interleukin 1 and protein synthesis inhibitors. J Immunol 138: 2149–2154PubMedGoogle Scholar
  32. Cerveny TJ, Fass DN, Mann KG (1984) Synthesis of coagulation factor V by cultured aortic endothelium. Blood 63: 1467–1474PubMedGoogle Scholar
  33. Cheifetz S, Weatherbee JA, Tsang MLS, Anderson JK, Mole JE, Lucas R, Massague J (1987) The transforming growth factor-/ß system, a complex pattern of cross- reactive ligands and receptors. Cell 48: 409–415PubMedCrossRefGoogle Scholar
  34. Cheifetz S, Bassols A, Stanley K, Ohta M, Greenberger J, Massague J (1988) Heterodimeric transforming growth factor ß: biological properties and interaction with three types of cell surface receptor. J Biol Chem 263: 10783–10789PubMedGoogle Scholar
  35. Cohen S (1962) Purification of a nerve-growth promoting protein from the mouse salivary gland and its neuro-cytotoxic antiserum. Proc Natl Acad Sci USA 46: 302–311CrossRefGoogle Scholar
  36. Cohen S, Carpenter G (1975) Human epidermal growth factor: isolation and chemical and biological properties. Proc Natl Acad Sci USA 72: 1317–1321PubMedCrossRefGoogle Scholar
  37. Collins T, Lapierre LA, Fiers W, Strominger JL, Pober JS (1986) Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A,B antigens in vascular endothelial cells and dermal fibroblasts in vitro. Proc Natl Acad Sci USA 83: 466–450Google Scholar
  38. Conti P, Cifone MG, Alesse E, Fieschi G, Angeletti PU (1985) Augmentation of thromboxane production in vitro by polymorphonuclears and macrophages exposed to IL1/LP. Agents Action 17: 390–391CrossRefGoogle Scholar
  39. DeGroot PG, Ottenhof-Rovers M, Mornik JA, Sixma JJ (1988) Evidence that the primary binding site of von Willebrand factor that mediates platelet adhesion on subendothelium is not collagen. J Clin Invest 82: 65–73CrossRefGoogle Scholar
  40. Degre M, Mellbye OJ, Clarke-Jenssen O (1983) Immune interferon in serum and synovial fluid in rheumatoid arthritis and related disorders. Ann Rheum Dis 42: 672–676PubMedCrossRefGoogle Scholar
  41. Dejana E, Brevario F, Erroi A, Bussolino F, Mussoni L, Gramse M, Pintucci G, Casali B, Dinarello CA, van Damme J, Montovani A (1987) Modulation of endothelial cell function by different molecular species of IL-1. Blood 69: 695–699PubMedGoogle Scholar
  42. De la Maza LM, Peterson EM, Fennie CW, Czarniecki CW (1985) The antichlamydial and anti-proliferation activities of recombinant murine interferon-gamma are not dependent upon tryptophan concentrations. J Immunol 135: 198–200Google Scholar
  43. Deuel TF, Huang JS (1984) Platelet-derived growth factor: structure, function and roles in normal and transformed cells. J Clin Invest 74: 669–676PubMedCrossRefGoogle Scholar
  44. Deuel TF, Senior KM, Chang D, Griffin GL, Heinrickson RL, Kaiser ET (1981) Platelet factor 4 is chemotactic for neutrophils and monocytes. Proc Natl Acad Sci USA 78: 4584–4587PubMedCrossRefGoogle Scholar
  45. Deuel TF, Senior KM, Huang JS, et al. (1982) Chemotaxis of monocytes and neutrophils to platelet-derived growth factor. J Clin Invest 69: 1046–1049PubMedCrossRefGoogle Scholar
  46. Dinarello CA (1986) IL-1: amino acid sequences, multiple biological activities and comparison with tumor necrosis factor (cachectin). Year Immunol 2: 68–89PubMedGoogle Scholar
  47. Dinarello CA (1988) Cytokines: interleukin-1 and tumor necrosis factor (cachectin) In: Gallin JI, Goldstein IM, Snyderman R (eds) Inflammation: basic principles and clinical correlates. Raven, New York, pp 195–208Google Scholar
  48. Duijvestijn AM, Schreiber AB, Butcher EC (1986) Interferon-y regulates an antigen specific for endothelial cells involved in lymphocyte traffic. Proc Natl Acad Sci USA 83: 9114–9118PubMedCrossRefGoogle Scholar
  49. Duncan MR, Berman B (1985) Gamma interferon is the lymphokine and beta interferon is the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation. J Exp Med 162: 516–527PubMedCrossRefGoogle Scholar
  50. Estes JE, Pledger WJ, Gillespie GY (1984) Macrophage-derived growth factor for fibroblasts and interleukin-1 are distinct entities. J Leuk Biol 35: 115–129Google Scholar
  51. Feldman G, Allen J, Swisher J, Pluznick D, Wahl L, Wahl S (1987) Susceptibility to streptococcal cell wall (SCW)-induced polyarthritis is associated with differential macrophage activation (Abstr) J Leuk Biol 42: 344Google Scholar
  52. Fleischmann J, Golde DW, Weisbart RH, Gasson JC (1986) Granulocyte-macrophage colony-stimulating factor enhances phagocytosis of bacteria by human neutrophils. Blood 68: 708–711PubMedGoogle Scholar
  53. Frater-Schroeder M, Risau W, Hallmann R, Gautschi P, Bohlen P (1987)Tumor necrosis factor type a, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc Natl Acad Sci USA 84: 5277–5281Google Scholar
  54. Gee AP, Boyle MDP, Munger KL, Lawman MJP, Young M (1983) Nerve growth factor: stimulation of polymorphonuclear Chemotaxis in vitro. Proc Natl Acad Sci USA 80: 721–728CrossRefGoogle Scholar
  55. Glenn K, Bowen-Pope DF, Ross R (1982) Platelet-derived growth factor. III. Identification of a platelet-derived growth factor receptor by affinity labelling. J Biol Chem 257: 5172–5176PubMedGoogle Scholar
  56. Goetzl EJ, Brash AP, Tauber AI, Oates JA, Hubbard WC (1980) Modulation of human neutrophil function by monohydroxyeicosatetraenoic acids. Immunology 39: 491–501PubMedGoogle Scholar
  57. Goldberg ID, Stemerman MB, Handin RI (1980) Vascular permeation of platelet factor 4 alters endothelial injury. Science 209: 611–612PubMedCrossRefGoogle Scholar
  58. Goldring MB, Krane SM (1987) Modulation by recombinant interleukin-1 of synthesis of types I and III collagens and associated procollagen mRNA levels in cultured human cells. J Biol Chem 262:16 724–16 729Google Scholar
  59. Goldyne ME, Stobo JD (1981) Immunoregulatory role of prostaglandins and related lipids. Crit Rev Immunol 2: 189–223Google Scholar
  60. Gospodarowicz D, Bialecki H, Tharkal TK (1979) The angiogenic activity of the fibroblast and epidermal growth factor. Exp Eye Res 28: 501–514PubMedCrossRefGoogle Scholar
  61. Gospodarowicz D, Ferrara N, Schweigerer L, Neufeld G (1987 a) Structural characterization and biological functions of fibroblast growth factor. Endocr Rev 8: 95–114Google Scholar
  62. Gospodarowicz D, Neufeld G, Schweigerer L (1987 b) Fibroblast growth factor: structural and biological properties. J Cell Physiol [Suppl] 5: 15–26Google Scholar
  63. Graham R, Ebert RH, Ratnoff OD, Moses JM (1965) Pathogenesis of inflammation. II. In vivo observations of the inflammatory effects of activated Hageman factor and brandykinin. J Exp Med 121: 807PubMedCrossRefGoogle Scholar
  64. Grinnell F, Feld M, Snell W (1979) The influence of cold insoluble globulin on platelet morphological response to substrata. Cell Biol Int Rep 3: 585PubMedCrossRefGoogle Scholar
  65. Gross JL, Moscatelli D, Rifkin DB (1983) Increased capillary endothelial cell protease activity in response to angiogenic stimuli in vitro. Proc Natl Acad Sci USA 80: 2623–2627PubMedCrossRefGoogle Scholar
  66. Gronwald RGK, Grant FJ, Haldeman BA, Hart CE, O’Hara PJ, Hagen FS, Ross R, Bowen-Pope DF, Murray MJ (1988) Cloning and expression of a cDNA coding for the human platelet-derived growth factor receptor: evidence for more than one receptor class. Proc Natl Acad Sci USA 85: 3435–3439PubMedCrossRefGoogle Scholar
  67. Guyre PM, Morganelli PM, Miller R (1983) Recombinant immune interferon increases immunoglobulin G Fc receptors on cultured human mononuclear phagocytes. J Clin Invest 72: 393PubMedCrossRefGoogle Scholar
  68. Halliwell B (1987) Oxidants and human disease: some new concepts. FASEB J 1: 358–364PubMedGoogle Scholar
  69. Heimark RL, Twardzik DR, Schwartz SM (1986) Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets. Science 233: 1078–1080PubMedCrossRefGoogle Scholar
  70. Heldin C-H, Johnsson A, Wennergren S, Wernstadt C, Betsholtz C, Westermark B (1986) A human osteosarcoma cell line secretes a growth factor structurally related to a homodimer of PDGF A-chains. Nature 319: 511–514PubMedCrossRefGoogle Scholar
  71. Heldin C-H, Backstrom G, Ostman A, Hammacher A, Rounstrand L, Rubin K, Nister M, Westermark B (1988) Binding of different dimeric forms of PDGF to human fibroblasts: evidence for two separate receptor types. EMBO J 7: 1387–1393PubMedGoogle Scholar
  72. Helle M, Brakenhoff JPJ, DeGroot ER, Aarden LA (1988) Interleukin 6 is involved in interleukin 1-induced activities. Eur J Immunol 18: 957–959PubMedCrossRefGoogle Scholar
  73. Hermann F, Cannistra SA, Levine H, Griffin JD (1985) Expression of interleukin 2 receptors on human peripheral blood monocytes. J Exp Med 162: 1111CrossRefGoogle Scholar
  74. Herron GS, Banda MJ, Clark EJ, Gavrilovic J, Werb Z (1986) Secretion of metal- loproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. J Biol Chem 261: 2814–2818PubMedGoogle Scholar
  75. Hirsch JG (1960) Comparative bactericidal activities of blood serum and plasma serum. J Exp Med 112: 15–22PubMedCrossRefGoogle Scholar
  76. Houssiau FA, Coulie PG, Olive D, van Snick J (1988 a) Synergistic activation of human T cells by interleukin 1 and interleukin 6. Eur J Immunol 18: 653–656Google Scholar
  77. Houssiau FA, DeVogelaer JP, van Damme J, Nagant de Deuxchaisnes C, van Snick J (1988 b) Interleukin 6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum 31: 784–788Google Scholar
  78. Ignotz RA, Massague J (1986) Transforming growth factor-/ß stimulates the expression of flbronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261: 4337–345PubMedGoogle Scholar
  79. Ignotz RA, Endo T, Massague J (1987) Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-/ß. J Biol Chem 262: 6443–6446PubMedGoogle Scholar
  80. Ihle JN, Rebal L, Keller J, Lee JC, Happel AJ (1982) Interleukin 3: possible roles in the regulation of lymphocyte differentiation and growth. Immunol Rev 63: 5–32PubMedCrossRefGoogle Scholar
  81. Isakov N, Wolfgang S, Altman A (1986) Signal transduction and intracellular events in T-lymphocyte activation. Immunol Today 7: 271–275CrossRefGoogle Scholar
  82. Jaffe EA, Hoyer LW, Nachman RL (1974) Synthesis of von Willebrand factor by cultured human endothelial cells. Proc Natl Acad Sci USA 71: 1906–1909PubMedCrossRefGoogle Scholar
  83. Jennische E, Skottner A, Hansson H-A (1987) Dynamic changes in insulin-like growth factor I immunoreactivity correlate to repair events in rat ear after freeze thaw injury. Exp Mol Pathol 47: 193–201PubMedCrossRefGoogle Scholar
  84. Jiminez SA, Freundlich B, Rosenbloom J (1984) Selective inhibition of human diploid fibroblast collagen synthesis by interferons. J Clin Invest 74: 1112–1116CrossRefGoogle Scholar
  85. Kalebic T, Garbisa S, Glaser B, Liotta LA (1983) Basement membrane collagen: degradation by migrating endothelial cells. Science 221: 281–283PubMedCrossRefGoogle Scholar
  86. Kaplan AP, Kay AB, Austen KF (1972) A prealbumin activator of prekallikrein. III. Appearance of chemotactic activity for neutrophils. J Exp Med 135: 81–97PubMedCrossRefGoogle Scholar
  87. Kaplan AP, Goetzl EJ, Austen KF (1973) The fibrinolytic pathway of human plasma. II. The generation of chemotactic activity by activation of plasminogen proactivator. J Clin Invest 52: 2591–2595PubMedCrossRefGoogle Scholar
  88. Kasuga M, van Obberghen E, Nissley SP, Rechler MM (1981) Demonstration of two subtypes of insulin-like growth factor receptors by affinity crosslinking. J Biol Chem 256: 5305–5308PubMedGoogle Scholar
  89. Kehrl JH, Wakefield LM, Roberts AB, Jakowlew S, Alvarez-Mon M, Derynck R, Sporn MB, Fauci AS (1986) Production of transforming growth factor-beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 163: 1037–1050PubMedCrossRefGoogle Scholar
  90. Keski-Oja J, Leof EB, Lyons RM, Coffey RJ, Moses HL (1986) Transforming growth factors and control of neoplastic growth. J Cell Biochem 33: 95–107CrossRefGoogle Scholar
  91. Klempner MS, Dinarello CA, Gallin JI (1978) Human leukocyte pyrogen induces release of specific granule contents from human neutrophils. J Clin Invest 61: 1330–1336PubMedCrossRefGoogle Scholar
  92. Klempner MS, Dinarello CA, Henderson WR, Gallin JI (1979) Stimulation of neutrophil oxygen-dependent metabolism by human leukocytic pyrogen. J Clin Invest 64: 996–1002PubMedCrossRefGoogle Scholar
  93. Krane SM, Dayer JM, Simon LS, Byrne LS (1985) Mononuclear cell-conditioned medium containing mononuclear cell factor (MCF), homologous with interleukin- 1, stimulates collagen and fibronectin synthesis by adherent rheumatoid synovial cells: effects of prostaglandin E2 and indomethacin. Coll Relat Res 5: 99–117PubMedGoogle Scholar
  94. Kream BE, Rowe DW, Gworek SC, Raiz LG (1980) Parathyroid hormone alters collagen synthesis and procollagen mRNA levels in fetal rat calvaria. Proc Natl Acad Sci USA 77: 5654–5658PubMedCrossRefGoogle Scholar
  95. Landolfo S, Cofano F, Giovarelli M, Prat M, Cavallo G, Forni G (1985) Inhibition of interferon may suppress allograft reactivity by T lymphocytes in vitro and in vivo. Science 229: 176–179PubMedCrossRefGoogle Scholar
  96. Lansdorp PM, Aarden LA, Calafat J, Zilberstein WP (1986) A growth factor-dependent B cell hybridoma. Curr Top Microbiol Immunol 132: 105–113PubMedCrossRefGoogle Scholar
  97. Larsen CG, Anderson AO, Apella E, Oppenheim JJ, Matsushima K (1989) The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 243: 1464–1466PubMedCrossRefGoogle Scholar
  98. Leibovich SJ, Ross R (1975) The role of macrophages in repair: a study with hydrocortisone and anti-macrophage serum. Am J Pathol 78: 71–91PubMedGoogle Scholar
  99. Leibovich SJ, Polverini PJ, Shepard HM, Wiseman DM, Shively V, Nuscir N (1987) Macrophage-induced angiogenesis is mediated by tumor necrosis factor-alpha. Nature 328: 630–632CrossRefGoogle Scholar
  100. Li AKC, Koroly MJ, Schattlenkech ME, Malt RA, Young M (1980) Nerve growth factor: acceleration of the rate of wound healing. Proc Natl Acad Sci USA 77: 4379–4381PubMedCrossRefGoogle Scholar
  101. Lotner GZ, Lynch JM, Betz SJ, Henson PM (1980) Human neutrophil-derived platelet activating factor. J Immunol 124: 676–684PubMedGoogle Scholar
  102. Luster AD, Ravetch JV (1987) Biochemical characterization of a y-interferon-inducible cytokine (IP–10) J Exp Med 166: 1084–1097Google Scholar
  103. Luster AD, Unkeless JC, Ravetch JV (1985) Gamma interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 315: 673–676CrossRefGoogle Scholar
  104. Lynch SE, Nixon JC, Colvin RB, Antoniades HN (1987) Role of platelet-derived growth factor in wound healing: synergistic effects with other growth factors. Proc Natl Acad Sci USA 84: 7696–7700PubMedCrossRefGoogle Scholar
  105. Maciag T, Kadish J, Wilkins L, Sternerman MB, Weinstein R (1982) Organizational behavior of human umbilical vein endothelial cells. J Cell Biol 94: 511–520PubMedCrossRefGoogle Scholar
  106. Madri JA, Stenn KS (1982) Aortic endothelial cell migration. I. Matrix requirements and composition. Am J Pathol 106: 180–186Google Scholar
  107. Mahmood T, Busch HM, Racis SP, Krey PR (1987) Lymphokines in inflammatory arthritis (Abstr) Arthritis Rheum [Suppl 4] 30: S83Google Scholar
  108. Marcum JA, Rosenberg RD (1984) Anticoagulantly active heparin-like molecules from vascular tissue. Biochemistry 23: 1730–1737PubMedCrossRefGoogle Scholar
  109. Marcus AJ, Sailer LB, Ullman HL, Broekman MJ, Islam N, Oglesby T, Gorman RR (1984) 12s,20-Dihydroxyeicosatetraeonic acid: a new eicosanoid synthesized by neutrophils from 12s-hydroxyeicosatetraeonic acid produced by thrombin- or collagen-stimulated platelets. Proc Natl Acad Sci USA 81: 903–907Google Scholar
  110. Marder SR, Chenoweth DE, Goldstein IM, Perez HD (1985) Chemotactic responses of human peripheral blood monocytes to the complement derived proteins C5a and C5a des arg. J Immunol 134: 3325–3331PubMedGoogle Scholar
  111. Marquardt H, Hunkapiller MW, Hood LE, Todaro GJ (1984) Rat transforming growth factor type I: structure and relation to epidermal growth factor. Science 223: 1079–1082PubMedCrossRefGoogle Scholar
  112. Martin BM, Gimbrone MA Jr, Unanue ER, Cotran RS (1981) Stimulation of non- lymphoid mesenchymal cell proliferation by a macrophage-derived growth factor. J Imunol 126: 1510–1515Google Scholar
  113. Massague J, Cheifetz S, Ignotz R, Boyd FT (1987) Multiple type-beta transforming growth factors and their receptors. J Cell Physiol [Suppl] 5: 43–48CrossRefGoogle Scholar
  114. May LT, Helfgott DC, Seghal PB (1986) Anti-ß-interferon antibodies inhibit the increased expression of HLA-B7 mRNA in tumor necrosis factor-treated human fibroblasts: structural studies of the ß2 interferon involved. Proc Natl Acad Sci USA 83: 8957–8961PubMedCrossRefGoogle Scholar
  115. McDonald JA, Kelly DG, Broekelmann J (1982) Role of fibronectin in collagen deposition: Fab, to the gelatin-binding domain of fibronectin inhibits both fibronectin and collagen organization in fibroblast extracellular matrix. J Cell Biol 92: 485PubMedCrossRefGoogle Scholar
  116. Mensing H, Czarnetozki BM (1984) Leukotriene B4 induces in vitro fibroblast Chemotaxis. J Invest Dermatol 82: 9–12PubMedCrossRefGoogle Scholar
  117. Metealf D (1985) The granulocyte-macrophage colony-stimulating factors. Science 229: 16–22CrossRefGoogle Scholar
  118. Miller JM (1985) The structure of fibril-forming collagens. Ann NY Acad Sci 460: 1–13PubMedCrossRefGoogle Scholar
  119. Miyazono K, Okabe T, Urabe A, Takaku F, Heldin CH (1987) Purification and properties of an endothelial cell growth factor from human platelets. J Biol Chem 262: 4098–4103PubMedGoogle Scholar
  120. Montesano R, Orci L (1988) Transforming growth factor ß stimulates collagen-matrix contraction by fibroblasts: implications for wound healing. Proc Natl Acad Sci USA 85: 4894–4897PubMedCrossRefGoogle Scholar
  121. Montesano R, Mossez A, Ryser J-E, Orci L, Vassali P (1984) Leukocyte interleukins induce cultured endothelial cells to produce a highly organized glycosaminoglycan- rich pericellular matrix. J Cell Biol 99: 1706–1715PubMedCrossRefGoogle Scholar
  122. Moscatelli D, Jaffe E, Rifkin DB (1980) Tetradecanoyl phorbol acetate stimulates latent collagenase production by cultured human endothelial cells. Cell 20: 343–351PubMedCrossRefGoogle Scholar
  123. Moses HL, Tucker RF, Leof EB, Coffey RJ Jr, Halper J, Shipley GD (1985) Type beta transforming growth factor is a growth stimulator and a growth inhibitor. Cancer Cells 3: 65–71Google Scholar
  124. Muggli R, Baumgartner HR (1973) Collagen induced platelet aggregation: requirement for tropocollagen multimers. Thromb Res 3: 715CrossRefGoogle Scholar
  125. Muller R, Bravo R, Burckhardt J, Curran T (1984) Induction of c-fos gene and protein by growth factors precedes activation of c-myc. Nature 312: 716–720PubMedCrossRefGoogle Scholar
  126. Munker R, Gasson J, Ogawa M, Koeffler HP (1986) Recombinant human necrosis factor induces production of granulocyte-macrophage colony stimulating factor mRNA and protein from lung fibroblasts and vascular endothelial cells in vitro. Nature 323: 79–82PubMedCrossRefGoogle Scholar
  127. Mustoe TA, Pierce GF, Thomason A, Gramates P, Sporn MB, Deuel TF (1987) Accelerated wound healing of incisional wounds in rats by transforming growth factor-/ß. Science 237: 1333–1338PubMedCrossRefGoogle Scholar
  128. Narayanan AS, Page RC (1983) Biosynthesis and regulation of typeV collagen in diploid human fibroblasts. J Biol Chem 258: 11694–11699PubMedGoogle Scholar
  129. Nathan CF (1987) Secretory products of macrophages. J Clin Invest 79: 319–326PubMedCrossRefGoogle Scholar
  130. Nathan CF, Yoshida R (1988) Cytokines: interferon-y. In: Gallin JI, Goldstein IM, Snyderman R (eds) Inflammation: basic principles and clinical correlates. Raven, New York, pp 229–251Google Scholar
  131. Nawroth P, Stern D (1986) Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 164: 740–749CrossRefGoogle Scholar
  132. Nawroth PP, Bark I, Handley D, Cassimeris J, Ches L, Stern D (1986) Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of inter- leukin 1. J Exp Med 163: 1363–1375PubMedCrossRefGoogle Scholar
  133. Nedwin GE, Svedersky LP, Bringman TS, Palladino MA Jr, Goeddel DV (1985) Effect of interleukin 2, interferon-gamma and mitogens on the production of tumor necrosis factors alpha and beta. J Immunol 135: 2492–2497PubMedGoogle Scholar
  134. Niall M, Ryan GB, O’Brien BJ (1982) The effect of epidermal growth factor on wound healing in mice. J Surg Res 33: 164–169PubMedCrossRefGoogle Scholar
  135. Nouri AME, Parrayi GS, Goodman SM (1984) Cytokines and the chronic inflammation of rheumatic disease. I. The presence of interleukin 1 in synovial fluids. Clin Exp Immunol 55: 295PubMedGoogle Scholar
  136. Ochs ME, Postlethwaite AE, Kang AH (1987) Identification of a protein in sera of normal individuals that inhibits fibroblast chemotactic and random migration in vitro. J Invest Dermatol 88: 183PubMedCrossRefGoogle Scholar
  137. Oikasinen J, Ryhanen L (1981) Cortisol decreases the concentration of translatable type-I procollagen mRNA species in the developing chick-embryo calvaria. Biochem J 198: 519–524Google Scholar
  138. Ooi BS, MacCarthy EP, Hsu A, Ooi YM (1983) Human mononuclear cell modulation of endothelial cell proliferation. J Lab Clin Med 102: 428–33PubMedGoogle Scholar
  139. Ortaldo JR, Longo DL (1988) Human natural lymphocyte effector cells: definition, analysis of activity, and clinical effectiveness. JNCI 80: 999–1010PubMedGoogle Scholar
  140. Palombella YJ, Yamashino DJ, Maxfield FR, Decker S J, Vilcek J (1987) Tumor necrosis factor increases the number of epidermal growth factor receptors on human fibroblasts. J Biol Chem 262: 1950–1954PubMedGoogle Scholar
  141. Parmley RT, Hurst RE, Takagi M, Spicer SS, Austin RL (1983) Glycosaminoglycans in human neutrophils and leukemic myoblasts: ultrastructural, cytochemical, immunological and biochemical characterization. Blood 61: 257–266PubMedGoogle Scholar
  142. Peacock EE, Madden JW (1966) Some studies on the effect of /ß-aminopropionitrate on collagen in healing wounds. Surgery 60: 7–12Google Scholar
  143. Philip R, Epstein LB (1986) Tumor necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, y-interferon and interleukin-1. Nature 323: 86–89PubMedCrossRefGoogle Scholar
  144. Pledger WJ, Stiles CD, Antoniades HN, Scher CD (1977) Induction of DNA synthesis in Balb/c 3T3 cells by serum components: réévaluation of the commitment process. Proc Natl Acad Sci USA 74: 4481–4485PubMedCrossRefGoogle Scholar
  145. Pober JS, Gimbrone MA Jr, Cotran RS, Reiss CS, Burakoff SJ, Fiers W, Ault KA (1983) la expression by vascular endothelium is inducible by activated T cells and human y interferon. J Exp Med 157: 1339–1353Google Scholar
  146. Pohlman TH, Stanness KA, Beatty PG, Ochs HD, Harlan JM (1986) An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide, interleukin 1, and tumor necrosis factor-alpha increases neutrophil adherence by a CDwl 8-dependent mechanism. J Immunol 136: 4548–4553PubMedGoogle Scholar
  147. Postlethwaite AE, Kang AH (1983) Latent lymphokines: isolation of human latent lymphocyte-derived chemotactic factor for fibroblasts. In: Oppenheim JJ, Cohen S (eds) Interleukins, lymphokines and cytokines. Proceedings of the third international lymphokine workshop. Academic, New York, pp 535–541Google Scholar
  148. Postlethwaite AE, Kang AH (1988) Fibroblasts. In: Gallin JI, Goldstein IM, Snyderman R (eds) Inflammation: basic principles and clinical correlates. Raven, New York, pp 577–597Google Scholar
  149. Postlethwaite AE, Snyderman R, Kang AH (1976) The chemotactic attraction of human fibroblasts to a lymphocyte-derived factor. J Exp Med 144: 1188–1203PubMedCrossRefGoogle Scholar
  150. Postlethwaite AE, Lachman LB, Mainardi CL, Kang AH (1983) Stimulation of fibroblast collagenase production by human interleukin-1. J Exp Med 157: 801–806PubMedCrossRefGoogle Scholar
  151. Postlethwaite AE, Keski-Oja J, Moses HL, Kang AH (1987) Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor /ß. J Exp Med 165: 251–256PubMedCrossRefGoogle Scholar
  152. Raines EW, Dower SK, Ross R (1989) IL-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science (in press)Google Scholar
  153. Rappolee DA, Mark D, Banda MJ, Werb Z (1988) Wound macrophages express TGF- a and other growth factors in vivo: analysis by mRNA phenotyping. Science 241: 708–712PubMedCrossRefGoogle Scholar
  154. Rinderknecht E, Humbel RE (1978 a) Primary structure of human insulin-like growth factor II. FEBS Lett 89: 283–286Google Scholar
  155. Rinderknecht E, Humbel RE (1978 b) The amino acid sequence of insulin-like growth factor I and its structural homology with proinsulin. J Biol Chem 253: 2769–2776Google Scholar
  156. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH, Fauci AS (1986) Transforming growth factor type /ß: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83: 4167–4171PubMedCrossRefGoogle Scholar
  157. Robinson BW, McLemore TL, Crystal RG (1985) Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. J Clin Invest 75: 1488–1495PubMedCrossRefGoogle Scholar
  158. Rola-Pleszcynski M, Lieu H, Hamel J, Lemaire I (1982) Stimulated human lymphocytes produce a soluble factor which inhibits fibroblast migration. Cell Immunol 74: 104–110CrossRefGoogle Scholar
  159. Rosenberg SA, Lotze MT (1986) Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes. Annu Rev Immunol 4: 681–709PubMedCrossRefGoogle Scholar
  160. Rosenberg SA, Lotze MT, Muul LM, Leitman S, Chang AE, Ettinghausen SE, Matory YL et al. (1985) Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med 313: 1485–1492PubMedCrossRefGoogle Scholar
  161. Ross R, Glomset B, Kariya B, Harker L (1974) A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci USA 71: 1207–1210PubMedCrossRefGoogle Scholar
  162. Ross R, Raines EW, Bowen-Pope DF (1986) The biology of platelet-derived growth factor. Cell 46: 155–169PubMedCrossRefGoogle Scholar
  163. Rossi P, Karsenty G, Roberts MB, Roche NS, Sporn MB, deCrombrugghe B (1988) A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-beta. Cell 52: 405–414PubMedCrossRefGoogle Scholar
  164. Rubin K, Terracio L, Ronnstrand L, Heldin CH, Klareskog L (1988) Expression of platelet-derived growth factor receptors is induced on connective tissue cells during chronic synovial inflammation. Scand J Immunol 27: 285–294PubMedCrossRefGoogle Scholar
  165. Sage H, Bornstein PL (1982) Endothelial cells from umbilical vein and hemangioendothelioma secrete basement membrane largely to the exclusion of interstitial collagens. Arteriosclerosis 2: 27–36PubMedCrossRefGoogle Scholar
  166. Sage H, Pritzel P, Bornstein P (1981) Characterization of cell matrix-associated collagens synthesized by aortic endothelial cells in culture. Biochem 20: 436–442CrossRefGoogle Scholar
  167. Sanchez-Madrid F, Nagey JA, Robbins E, Simon P, Springer TA (1983) A human leukocyte antigen family with distinct a-subunits and a common /ß-subunit: the lymphocyte function associated antigen (LFA-1), the C3bi complement receptor (OKMl/Mac-1) and the pi 50,95 molecule. J Exp Med 158: 586PubMedCrossRefGoogle Scholar
  168. Sandberg N (1964) Time relationship between administration of cortisone and wound healing in rats. Acta Chir Scand 127: 446–55PubMedGoogle Scholar
  169. Sato N, Goto T, Haranaka K, Satoni N, Nariuchi H, Mano-Hirano Y, Sawasaki Y (1986) Actions of tumor necrosis factor on cultured vascular endothelial cells: morphologic modulation, growth inhibition and cytotoxicity. JNCI 76: 113Google Scholar
  170. Schall TJ, Jongstra J, Dyer BJ, Jorgensen J, Clayberger C, Davis MM, Krensky AM (1988) A human T cell specific molecule is a member of a new gene family. J Immunol 141: 1018–1025PubMedGoogle Scholar
  171. Schapira M, Despland E, Scott CF, Boxer LA, Colman RW (1982) Purified human plasma kallikrein aggregates human blood neutrophils. J Clin Invest 69: 1199–1201PubMedCrossRefGoogle Scholar
  172. Scheiwiller E, Guler HP, Merryweather J, Scandella C, Maerki W, Zapf J, Froesch ER (1986) Growth restoration of insulin-deficient diabetic rats by recombinant human insulin-like growth factor I. Nature 323: 169–171PubMedCrossRefGoogle Scholar
  173. Scher CD, Shephard RC, Antoniades HN, Stiles CD (1979) Platelet-derived growth factor and the regulation of the mammalian fibroblast cell cycle. Biochem Biophys Acta 560: 212–241Google Scholar
  174. Schmidt JA, Mizel SB, Cohen D, Green I (1982) Interleukin 1, a potential regulator of fibroblast proliferation. J Immunol 128: 2177–2182PubMedGoogle Scholar
  175. Schreiber AB, Winkler ME, Derynck R (1986) Transforming growth factor-a: a more potent angiogenic mediator than epidermal growth factor. Science 232: 1250–1253PubMedCrossRefGoogle Scholar
  176. Schultz GS, White M, Mitchell R, Brown G, Lynch J, Twardzik DR, Todaro GJ (1987) Epithelial wound healing by transforming growth factor-a and vaccinia growth factor. Science 235: 350–352PubMedCrossRefGoogle Scholar
  177. Seppa H, Seppa S, Yamada KM (1980) The cell binding fragment of fibronectin and platelet-derived growth factor are chemoattractants for fibroblasts. J Cell Biol 87:323 aGoogle Scholar
  178. Shahabuddin S, Kumar S, West D, Arnold F (1985) A study of angiogenesis factors from five different sources using a radioimmunoassay. Int J Cancer 35: 87–91PubMedCrossRefGoogle Scholar
  179. Shallaby MR, Aggarwal BB, Rinderknecht E, Sverdersky LP, Finkle BS, Palladino MA Jr (1985) Activation of human polymorphonuclear neutrophil function by interferon gamma and tumor necrosis factors. J Immunol 135: 2069–2073Google Scholar
  180. Sharon M, Siegel JP, Tosato G, Yodoi J, Gerrard TL, Leonard WJ (1988) The human interleukin 2 receptor /ß chain (p70). Direct identification, partial purification and patterns of expression on peripheral blood mononuclear cells. J Exp Med 167: 1265–1270PubMedCrossRefGoogle Scholar
  181. Shimokado K, Raines EW, Madtes DK, Barrett TB, Benditt EP, Ross R (1985) A significant part of macrophage-derived growth factor consists of at least two forms of PDGF. Cell 43: 277–286PubMedCrossRefGoogle Scholar
  182. Sieff CA (1987) Hematopoietic growth factors. J Clin Invest 79: 1549–1557PubMedCrossRefGoogle Scholar
  183. Simpson DW, Ross R (1972) The neutrophilic leukocyte in wound repair: a study with anti-neutrophil serum. J Clin Invest 51: 2009–2023PubMedCrossRefGoogle Scholar
  184. Sluiter W, Elzenga-Claasen I, Hulsing-Hesselink E, van Furth R (1983) Presence of the factor increasing monocytopoiesis ( FIM) in rabbit peripheral blood during acute inflammation. J Reticuloendothel Soc 34: 235–252PubMedGoogle Scholar
  185. Sluiter W, Hulsing-Hesselink E, Elzenga-Classen I, van Hemsberger-Oomens LWM, van der Voort van der Kleij-van Andel A, van Furth R (1987) Macrophages as origin of factor increasing monocytopoiesis. J Exp Med 166: 909–922PubMedCrossRefGoogle Scholar
  186. Smith P, Lamerson C, Wong HL, Wahl SM (1989) Granulocyte-macrophage colony- stimulting factor augmentation of leukocyte effector function. J Immunol (in press)Google Scholar
  187. Smith RJ, Speziale SC, Bowman BJ (1985) Properties of interleukin-1 as a complete secretogogue for human neutrophils. Biochem Res Commun 130:1233–1240Google Scholar
  188. Snyderman R, Uhling RJ (1988) Stimulus-response coupling mechanisms. In: Gallin JI, Goldstein IM, Snyderman R (eds) Inflammation: basic principles and clinical correlate. Raven, New York, pp 309–323Google Scholar
  189. Spencer EM, Skover G, Hunt TK (1988) Somatomedins: do they play a pivotal role in wound healing? In: Barbul A, Pines E, Caldwell M, Hunt TK (eds) Growth factors and other aspects of wound healing: biological and clinical implications. Liss, New York, pp 103–116Google Scholar
  190. Sporn MB, Roberts AB, Wakefield LM, de Crombrugghe B (1987) Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol 105: 1039–1045PubMedCrossRefGoogle Scholar
  191. Steinman BU, Abe S, Martin GR (1982) Modulation of type I and type II collagen production in normal and mutant skin fibroblasts by cell density, prostaglandin E2 and epidermal growth factor. Coll Relat Res 2: 185–195Google Scholar
  192. Stephenson ML, Krane SM, Amento EP, McCroskery PA, Byrne M (1985) Immune interferon inhibits collagen synthesis by rheumatoid synovial cells associated with decreased levels of procollagen mRNAs. FEBS Lett 180: 43–50PubMedCrossRefGoogle Scholar
  193. Stern D, Bank I, Nawroth P, Cassimeris J, Kisiel W, Fenton JW, Dinarello CA, Chess L, Jaffe EA (1985) Self regulation of procoagulant events on the endothelial cell surface. J Exp Med 162: 1223–1228PubMedCrossRefGoogle Scholar
  194. Stiles CD, Capone GT, Scher CD, Antoniades HN, Wyk JJ, Pledger WJ (1979) Dual control of cell growth by somatomedins and platelet-derived growth factor. Proc Natl Acad Sci USA 76: 1279–1283PubMedCrossRefGoogle Scholar
  195. Stroobant P, Waterfield MD (1984) The c-sis gene encodes a precursor of the B chain of platelet-derived growth factor. EMBO J 3: 921–928Google Scholar
  196. Sugarman BJ, Aggarwal BB, Figari IS, Palladino MA, Shepard HM (1985) Recombinant human tumor necrosis factor-a: effects on proliferation of normal and transformed cells. Science 230: 943–945PubMedCrossRefGoogle Scholar
  197. Sullivan R, Gans PJ, McCarrol LA (1983) The synthesis and secretion of granulocyte- monocyte colony stimulating activity (CSA) by isolated human monocytes: kinetics of the response to bacterial endotoxin. J Immunol 130: 800–807PubMedGoogle Scholar
  198. Takemura S, Rössing TH, Perlmutter DH (1986) A lymphokine regulates expression of alpha-1-protease inhibitor in human monocytes and macrophages. J Clin Invest 77: 1207–1213PubMedCrossRefGoogle Scholar
  199. Thompson JA, Anderson KD, Di Pietro JM, Zwiebel JA, Zametta M, Anderson WF, Maciag T (1988) Site-directed neovessel formation in vivo. Science 241: 1349–1352PubMedCrossRefGoogle Scholar
  200. Todaro GJ, Fryling C, DeLarco JE (1980) Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors. Proc Natl Acad Sci USA 77: 5258–5262PubMedCrossRefGoogle Scholar
  201. Tolstoshev P, Haber R, Trapne BC II, Crystal RB (1981) Procollagen mRNA levels and activity and collagen synthesis during fetal development of sheep lung and skin. J Biol Chem 256: 9672–9679PubMedGoogle Scholar
  202. Tsunawaki S, Sporn M, Ding A, Nathan C (1988) Deactivation of macrophages by transforming growth factor-/ß. Nature 334: 260–262PubMedCrossRefGoogle Scholar
  203. Turk CW, Dohlman TG, Goetzl EJ (1987) Immunological mediators of wound healing and fibrosis. J Cell Physiol [Suppl] 5: 89–93CrossRefGoogle Scholar
  204. Unkeless JC, Gordon SC, Reich E (1974) Secretion of plasminogen activator by stimulated macrophages. J Exp Med 139: 834–850PubMedCrossRefGoogle Scholar
  205. Van Furth R, Diesselhoffden Dulk MMC, Mattie H (1973) Quantitative study on the production and kinetics of mononuclear phagocytes during an acute inflammatory reaction. J Exp Med 138: 1314–1330PubMedCrossRefGoogle Scholar
  206. Van Waarde D, Hulsing-Hesselink E, Sandkuyl LA, van Furth R (1977) Humoral regulation of monocytopoiesis during the early phase of an inflammatory reaction caused by particulate substances. Blood 50: 141–153PubMedGoogle Scholar
  207. Van Waarde D, Hulsing-Hesselink E, van Furth R (1978) Humoral control of monocytopoiesis by an activator and an inhibitor. Agents Actions 8: 423–437CrossRefGoogle Scholar
  208. Vassali JD, Dayer JM, Wohlwend A, Belin D (1984) Concomitant secretion of prourokinase and of a plasminogen activator inhibitor by cultured human mono-cytes-macrophages. J Exp Med 159: 1653–1668CrossRefGoogle Scholar
  209. Vlassara H, Brownlee M, Cerami A (1985) High affinity receptor mediated uptake and degradation of glucose modified proteins: a potential mechanism for the removal of senescent macromolecules. Proc Natl Acad Sci USA 82: 5588–5592PubMedCrossRefGoogle Scholar
  210. Vlassara H, Brownlee M, Manogue KR, Dinarello CA, Pasagian A (1988) Cachec- tin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. Science 240: 1546–1548PubMedCrossRefGoogle Scholar
  211. Vlodavsky I, Fridman R, Sullivan R, Sasse J, Klagsburn M (1987) Aortic endothelial cells synthesize basic fibroblast growth factor which remains cell associated and platelet-derived growth factor-like protein which is secreted. J Cell Physiol 131: 402–408PubMedCrossRefGoogle Scholar
  212. Wahl LM, Wahl SM, Mergenhagen SE, Martin GR (1975) Collagenase production by lymphokine activated macrophages. Science 187: 261–263PubMedCrossRefGoogle Scholar
  213. Wahl SM (1988) Mononuclear cells and fibrosis. In: Gallin JI, Goldstein IM, Snyderman R (eds) Inflammation: basic principles and clinical correlates. Raven, New York, pp 841–860Google Scholar
  214. Wahl SM, Gately CL (1983) Modulation of fibroblast growth by a lymphokine of human T-cell and continuous T-cell line origin. J Immunol 130: 1226–1230PubMedGoogle Scholar
  215. Wahl SM, Malone DG, Wilder RL (1985) Spontaneous production of fibroblast activating factor(s) by synovial inflammatory cells. A potential mechanism for enhanced tissue destruction. J Exp Med 161: 210–222PubMedCrossRefGoogle Scholar
  216. Wahl SM, Allen JB, Dougherty S, Evequoz E, Pluznik DH, Wilder RL, Hand AR, Wahl LM (1986 a) T lymphocyte-dependent evolution of bacterial cell wall-induced hepatic granulomas. J Immunol 137: 2199–2209Google Scholar
  217. Wahl SM, Hunt DA, Allen JB, Wilder RL, Paglia L, Hand AR ( 1986 b) Bacterial cell wall induced hepatic granulomas. An in vivo model of T cell dependent fibrosis. J Exp Med 163: 884–902PubMedCrossRefGoogle Scholar
  218. Wahl SM, Hunt D, Wakefield L, McCartney-Francis N, Wahl L, Roberts A, Sporn M ( 1987 a) Transforming growth factor beta ( TGF-/ß) induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci USA 84: 5788–5792PubMedCrossRefGoogle Scholar
  219. Wahl SM, McCartney-Francis N, Hunt DA, Smith PD, Wahl LM, Katona IM (1987 b) Monocyte interleukin 2 receptor gene expression and interleukin 2 augmentation of microbicidal activity. J Immunol 139: 1342–1347PubMedGoogle Scholar
  220. Wahl SM, Hunt DA, Wong HL, Dougherty S, McCartney-Francis N, Wahl LM, El- lingsworth L, Schmidt JA, Hall G, Roberts AB, Sporn MB (1988 a) Transforming growth factor-/ß is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation. J Immunol 140: 3026–3032Google Scholar
  221. Wahl SM, Hunt DA, Bansal G, McCartney-Francis N, Ellingsworth L, Allen JB (1988 b) Bacterial cell wall-induced immunosuppression: role of transforming growth factor beta. J Exp Med 168: 1403–1417PubMedCrossRefGoogle Scholar
  222. Wahl SM, Wong HL, McCartney-Francis N (1989) Role of growth factors in inflammation and repair. J Cell Biochem (40: 193–199 )Google Scholar
  223. Wallis WJ, Beatty PG, Ochs HD, Harlan JM (1985) Human monocyte adherence to cultured vascular endothelium: monoclonal antibody-defined mechanisms. J Immunol 35: 2323–2330Google Scholar
  224. Weisbart RH, Golde DW, Spolter L, Eggena P, Rinkerknecht H (1979) Neutrophil migration inhibition factor from T lymphocytes (NIF-T): a new lymphokine. Clin Immunol Immunopathol 14: 441–448PubMedCrossRefGoogle Scholar
  225. Weisbart RH, Golde DW, Clark SC, Wong GG, Gasson JC (1985) Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator. Nature 314: 361–363PubMedCrossRefGoogle Scholar
  226. Weiss A, Imboden J, Hardy K, Manger B, Terhorst C, Stobo J (1986) The role of T3/antigen receptor complex in T-cell activation. Annu Rev Immunol 4: 593–619PubMedCrossRefGoogle Scholar
  227. Weksler BB (1988) Platelets. In: Gallin JI, Goldstein IM, Snyderman R (eds) Inflammation: basic principles and clinical correlates. Raven, New York, pp 543–558Google Scholar
  228. Welsh CE, Waite BM, Thomas MJ, DeChatelet LR (1981) Release and metabolism of arachidonic acid in human neutrophils. J Biol Chem 256: 7228–7234Google Scholar
  229. Werb Z, Gordon S (1975) Elastase secretion by stimulated macrophages: characterization and regulation. J Exp Med 142: 361–377PubMedCrossRefGoogle Scholar
  230. Whiteside TL, Wonall JG, Prince RK, Buckingham RB, Rodnan GP (1986) Soluble mediators from mononuclear cells increase the synthesis of glycosaminoglycans by dermal fibroblast cultures derived from normal subjects and progressive systemic sclerosis patients. Arthritis Rheum 28: 188–197CrossRefGoogle Scholar
  231. Wilder RL, Calandra GB, Garvin AJ, Wright KD, Hansen CT (1982) Strain and sex variation in the susceptibility to streptococcal cell wall-induced polyarthritis in the rat. Arthritis Rheum 25: 1064–1072PubMedCrossRefGoogle Scholar
  232. Wilder RL, Allen JB, Wahl LM, Calandra GB, Wahl SM (1983) The pathogenesis of group A streptococcal cell wall-induced polyarthritis in the rat: comparative studies in arthritis resistant and susceptible inbred rat strains. Arthritis Rheum 26: 1442–1451PubMedCrossRefGoogle Scholar
  233. Williams JD, Lee TH, Lewis RA, Austen F (1985) Intracellular retention of the 5- lipoxgenase pathway product, leukotriene B4, by human neutrophils activated with unopsonized zymosan. J Immunol 143: 2624–2630Google Scholar
  234. Williams JD, Straneva JE, Cooper S, Shadducj RK, Waheed A, Gillis S, Urdal D, Broxmeyer HE (1987) Interactions between purified murine colony-stimulating factors (natural CSF-1, recombinant GM-CSF and recombinant IL-3) on the in vivo proliferation of purified murine granulocyte-macrophage progenitor cells. Exp Hematol 15: 1007–1012PubMedGoogle Scholar
  235. Williams LT, Antoniades HN, Goetzl EJ (1983) Platelet-derived growth factor stimulates mouse 3T3 cell mitogenesis and leukocyte Chemotaxis through different structural determinants. J Clin Invest 72: 1759–1763PubMedCrossRefGoogle Scholar
  236. Wölpe SD, Davatelis G, Sherry B, Beutler B, Hesse DG, Nguyen HT, Moldawer LL, Nathan CF, Lowry SF, Cerami A (1988) Macrophages secrete a novel heparin- binding protein with inflammatory and neutrophil chemokinetic properties. J Exp Med 167: 570–581PubMedCrossRefGoogle Scholar
  237. Wood DD, Ihrie EJ, Dinarello CA, Cohen PL (1983) Isolation of an interleukin-l-like factor from human joint effusion. Arthritis Rheum 26: 975–983PubMedCrossRefGoogle Scholar
  238. Wright SD, Jong MTC (1986) Adhesion-promoting receptors on human macrophages recognize E. coli by binding to lipopolysaccharide. J Exp Med 164: 1876–1888PubMedCrossRefGoogle Scholar
  239. Wright SD, Silverstein SC (1983) Receptors for C3b and C3bi promote phagocytosis but not the release of toxic oxygen from human phagocytes. J Exp Med 158: 2016–2023PubMedCrossRefGoogle Scholar
  240. Wyler DJ, Stadecker MJ, Dinarello CA, O’Dea JF (1984) Fibroblast stimulation in schistosomiasis. V. Egg granuloma macrophages spontaneously secrete a fibroblast stimulating factor. J Immunol 132: 3142–3148PubMedGoogle Scholar
  241. Yocum DE, Allen JB, Wahl SM, Calandra GB, Wilder RL (1986) Inhibition by cyclosporin A of streptococcal cell wall-induced arthritis and hepatic granulomas in rats. Arthritis Rheum 29: 262–273PubMedCrossRefGoogle Scholar
  242. Yoshino S, Cromartie WJ, Schwab JH (1985) Inflammation induced by bacterial cell wall fragments in the rat air pouch. Comparison of rat strains and measurement of arachadonic acid metabolites. Am J Pathol 121: 327–336PubMedGoogle Scholar
  243. Zilberstein A, Ruggieri R, Korn JH, Revel M (1986) Structure and expression of cDNA and genes for human interferon-beta-2, a distinct species inducible by growth-stimulating cytokines. EMBO J 5: 2529–2537PubMedGoogle Scholar
  244. Zucali JR, Dinarello CA, Obion DJ, Gross MA, Anderson L, Weiner RS (1986) Interleukin 1 stimulates fibroblasts to produce granulocyte-macrophage colony-stimulating activity and prostaglandin E2. J Clin Invest 77: 1857–1863PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • H. L. Wong
  • S. M. Wahl

There are no affiliations available

Personalised recommendations